Blister Packaging Market Outlook
Demand for blister packaging continues to grow steadily as pharma industry ramps up production output. Features of blister packaging such as product protection and safety, cost-effectiveness, increased graphics area is increasing the sales footprint. Adoption of sustainable packaging solutions is further fueling the sales.
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key growth drivers and restraints impacting blister packaging industry. The report also tracks global sales and trends of blister packaging in 20+ high-growth markets across the world.
Historical and Future Outlook
Blister packaging format has been the preferred choice by pharmaceutical companies since the past decade for packaging of oral form drugs. Also, high popularity of mono layer and multi-layer blister packaging formats has propelled the growth.
While the steady expansion of the pharmaceutical industry is driving demand, applications in food, industrial goods, consumer goods, and others is further boosting adoption. According to Future Market Insights (FMI), the global blister packaging market is anticipated to expand at 6.4% CAGR during the forecast period from 2021 to 2031.
Key Trends Driving Blister Packaging Sales
Increase in expenditure on healthcare, coupled with rising demand for extensive range of pharmaceutical drugs has led pharmaceutical companies to opt outsourcing through contract development. Contract development and manufacturing organizations also provide services related to active pharmaceutical production (API), drug product development and packaging services.
For Instance, Skyepharma Production SAS, a Europe-based contract development and manufacturing organization, provides drug development and packaging services to pharmaceutical, biotech and consumer health industries in Europe.
Similarly, Recipharm AB, another pharmaceutical contract development and manufacturing organizations, provide services associated with active pharmaceutical production (API) and blister packaging.
As leading pharmaceutical companies are swiftly increasing their outsourcing activities in order to reduce manufacturing and packaging cost, the outlook of blister packaging market is changing fast.
This current trend of outsourcing is also raising the production volume of pharmaceutical drugs which are packed in blister packaging formats. All these factors are anticipated to drive sales of blister packaging during the foreseeable future.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
What will be the Impact of Increasing R&D Activities on Blister Packaging Sales?
By considering the current market scenarios, prominent pharmaceutical companies are investing heavily in research and development activities in order to enhance and update the current pharmaceutical product pipelines. These pharma companies are spending significantly on development of new products and drugs in order to fulfil the requirement.
For instance, leading pharmaceutical companies such as Novartis AG, Takeda, Johnson & Johnson and AstraZeneca had more than 200 pharmaceutical drugs in their R & D pipeline in 2020. Furthermore, on the back of involvement of private sector in pharmaceutical industry, small scale pharmaceutical companies are also spending considerably on launching of new products.
This rise in R&D activities among the small as well as big scale pharmaceutical industries to launch new pharma products in the market including oral form drugs is creating massive demand for pharmaceutical packaging including blister packaging.
Child-Resistant and Senior-Friendly Packaging – Key Focus Areas
Child-resistant blister offers premium level of safety, security and prevent children from gaining access to the medication. Since the last few years, packaging manufacturers are constantly emphasizing on design and development of child-resistant and temper-evident blister packaging in order to reduce the cases of accidental medicine-related poisoning in children.
According to the report titled “Adverse Drug Events in Children” published by the Centers for Disease Control and Prevention (CDC), approximately 200,000 children (17 years old or younger) visit emergency departments each year because of adverse drug events. Amcor plc.’s recently launched its child-resistant blister packaging which is designed with additional safety features to prevent children from gaining access to the contents inside. Also, these child resistant blister packs are senior-friendly which makes them more suitable for versatile applications in the field of medicine.
What is the Commercial Potential of Smart Blister Packaging?
The global pharmaceutical and food industry is experiencing a growing trend of advanced design and technological features in packaging formats including blister packaging. Conventional and widely used pharmaceutical blister packs are being incorporated with sophisticated digital technologies that feature advanced functionality for end user and patient convenience.
Digital technology in blister packs provide a broad range of functionalities such as dosage reminders, time and temperature indication, product quality indication, and others. Thus by shifting preference of such technology-oriented consumers towards advanced pharmaceutical packaging solutions, blister packaging manufacturers are being highly benefitted.
Surge in demand for blister packaging formats from end-users in Asia, Europe, and North American countries continues to grow. Besides this, increase in healthcare expenditure and exponential growth of pharmaceutical and food industries in these regions is expected to create ample of opportunities for blister packaging manufacturers.
As majority of key market players are headquartered in Western Europe and North America, the competitiveness and barrier to entry for new entrants is considerably high in these regions. On the other hand, MEA, Japan, and Latin America have lower number of blister packaging manufacturers, thereby resulting in reduced competitiveness and barrier to entry in the market. Furthermore, as the relevance of blister packaging in pharmaceutical and non-pharmaceutical sectors is rising, the overall demand-supply trajectory for blister packaging is fairly good in all respective regions.
How the United States Pharmaceutical Industry is Becoming Profitable for Blister Packaging Manufacturers?
As per FMI’s analysis, the U.S. pharmaceutical industry has witnessed significant growth in the last couple of years. This astonishing market growth is majorly driven by rise in per capita consumption and expenditure on pharmaceutical drugs and a significant presence of prominent pharmaceutical companies in the U.S.
According to the Organization for Economic Co-operation and Development (OECD), in 2019, the total healthcare spending per capita in the U.S. was nearly US$ 11,500 which is far more than other countries.
The healthcare spending in the U.S. is likely to increase over time owing to the geriatric population and rise in chronic illnesses. Presence of pharmaceutical giants such as Pfizer Inc., Johnson & Johnson, Eli Lilly and Company, AbbVie Inc. and others in the U.S is raising the overall production of pharmaceutical drugs, which in turn is fueling the sales of blister packaging. As a result, the key players in the market are targeting the U.S. to increase their sales footprint.
India is the New Revenue-generating Hub for Blister Packaging Market Players
India is one of the largest pharmaceutical manufacturers and exporters. Low cost of production and packaging led manufacturers to expand their manufacturing facilities in India over the past decade. As per the India Brand Equity Foundation (IBEF organization), India’s pharmaceutical export was US$ 16.2 Bn in 2019.
Highly advanced healthcare infrastructure, coupled with increase in pharmaceutical spending is bolstering the demand for blister packaging. India is also gearing up for high scale production of generic as well as branded drugs segments on the back of government initiatives.
According to the Department of Pharmaceuticals of India, a flurry of initiatives have been taken by the Government of India in the field of medicines such as Pharma Industry Promotion, CPSEs (Manufacturing of Strategic Pharma Products), and others. All these factors are likely to offer significant growth opportunities to blister packaging manufacturers in terms of revenue generation.
What Key Factors are Driving Blister Packaging Sales in Germany?
German pharmaceutical industry is projected to generate significant demand for blister packs during the forecast period. The consistently growing demand for blister packaging in Germany is mainly driven by the rise in pharmaceutical R & D expenditure and production.
As per the European Federation of Pharmaceutical Industries and Associations, the total R&D expenditure on pharmaceutical sector in Germany for 2019 was more than US$ 8.5 Bn. Furthermore, the rapidly rising COVID-19 cases in European countries including Germany is creating massive demand for blister packs for pharmaceutical drugs. FMI predicts that, the future demand for blister packs in Germany will be eye-catching on the back of these factors.
Rapid Increase in Geriatric Population Supplementing Sales in China
In the last couple of years, the demand for prescription drugs in China have witnessed significant surge on the back of rapid increase in elderly population. As per the EIU, Espicom, the population of China is nearly 1.4 Bn in 2019, out of which ~10% population is more than age of 65. This aging population in China is generating considerable demand for oral form drugs owing to weaker immune systems and higher incidence of illness. FMI predicts that, the aging population in China is projected to rise in future and will create the positive impact on the demand for blister packaging.
Japan in the Spotlight for the Blister Packaging Manufacturers
Japan has emerged as a lucrative market for the blister packaging manufacturers owing to the steadily rising demand from the key end-use industries such as pharmaceuticals, food, industrial goods, consumer goods, and others. As per the statistics revealed by the Government of Japan, the prescription and non-prescription pharmaceutical industry in Japan was worth more than US$ 87 billion in 2018 and is growing steadily.
Being home to the world’s oldest population, where almost one-third population is over the age of 65, Japan is highly lucrative for blister packaging manufacturers. Furthermore, various governmental rules and guidelines are working in favor of blister packaging suppliers in Japan.
For instance, in Japan, drug products granted orphan drug designation are automatically granted priority review. No doubt that the key players are eyeing Japan in order to expand further in the coming years.
How Thermoforming Technology is Contributing to Higher Sales of Blister Packaging?
Accounting for more than 3/4th portion of the market share, the thermoforming technology segment continues to propel the growth of the blister packaging suppliers. Faster speed of production and low cost of manufacturing of thermoforming technology as compared to cold forming technology are crucial factors catering to the high requirement of this technology.
As per FMI Analysis, the target segment is projected to expand by 1.9x times to its value during the period from 2021 to 2031.
Why Demand for Plastic-based Blister Packaging is High?
The demand for plastic and aluminium-based blister packaging is rapidly increasing since past couple of years. This is attributed to rise in requirement of moisture and air resistant packaging solutions among end-users. Blister packaging with barrier film lamination ensures maximum protection to the stored product from harsh environmental conditions such as water vapours, dust, UV rays, etc.
Additionally, key players are doing two-fold investments in research and development activities in order to make blister packaging more suitable for consumable products. For instance, Wasdell Group, a Swidon based packaging manufacturer and supplier, has developed world’s first plastic blister packs that are biodegradable when exposed to landfill.
This innovation is expected to reduce environmental pollution up to certain extent. Attributing to the use of biodegradable plastics in blister packaging, the consumption of plastic blister packs is expected to reach over 2.8 Mn Tonnes by the end of 2026.
Why Pharmaceutical and Veterinary & Nutraceuticals Are Holding More than Half of the Market Share?
Amid COVID-19 pandemic, hygiene and cleanroom packaging are the prime concern of the consumers. Instead of increasing risk of contamination using the bulk quantity of health supplements, these end users are more inclined towards unit dosing. Therefore, they are gradually shifting from glass jar or bottle packaging formats to blister packaging.
As per FMI analysis, collectively, pharmaceuticals and veterinary & nutraceuticals segments are estimated to hold more than 50% of the blister packaging market share through 2031. Increase in production of oral drug forms such as tablets and capsules is further driving the demand for blister packs. These two segments are collectively anticipated to provide the total incremental opportunity of US$ 6.5 Bn during the forecast period.
When it comes to protecting the highly sensitive pharmaceutical medicines, high barrier packaging films play a crucial role. On the back of this factor, leading packaging companies operating in the global blister packaging market are introducing blister packaging made up of high barrier packaging films which maintain the integrity and quality of tablets and capsules against moisture and oxygen.
For instance, Recently, Klockner Pentaplast, one of the leading pharmaceutical packaging manufacturers, has introduced kpMax, a four-layer structure blister packaging, specially designed for oxygen and moisture sensitive pharmaceuticals products. The same packaging innovation provides several benefits such as 30% higher production output, minimizes blister card size which reduces secondary packaging while requiring minimum transition cost.
- In January 2020, AptarGroup Inc., the leader in material science and active packaging solutions, launched fully integrated Active-Blister packaging solution combining moisture absorption and oxygen scavenging properties. The company added the combined moisture absorption and oxygen scavenging capability to the Activ-Film product in order to provide end users with a highly integrated solution for pharmaceutical products which are highly sensitive to moisture and oxidation.
- In May 2018, Tekni-Plex launched SBC 240 performance-oriented super barrier coated thermoformable film for pharmaceuticals blister packs. The newly invented triplex structure SBC 240 thermoformable film is ideal for highly sensitive pharmaceuticals, probiotics, nutraceuticals and other related products.
Moreover, manufacturers of blister packs are constantly trying to keep up with the green trends. For instance, in 2019, Huhtamaki Oyj, one of the packaging giants, has introduced recyclable Push Tab blister solution for pharmaceutical industry with highest barrier properties.
Some of the leading companies operating in the blister packaging market are:
- Amcor plc
- Constantia Flexibles GmbH
- Sonoco Products Company
- Winpak Ltd.
- West Rock Company
- Honeywell International, Inc.
- Uflex Ltd
- Tekni-Plex, Inc.
- ACG Pharmapack Pvt. Ltd.
- Klockner Pentaplast Group
*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.
Scope of the Report
Historical Data Available for
USD Million for value and tonnes for Volume
Key Regions Covered
North America, Latin America, Western Europe, Eastern Europe, Asia Pacific ex. Japan, Middle East & Africa, and Japan
Key Countries Covered
US, Canada, Brazil, Germany, U.K., France, Italy, Spain, Poland, Russia, China, , India, GCC, South Africa, Northern Africa, Australia, and New Zealand
Key Segments Covered
Product Type, Material Type, Technology Type, End Use, and Region
Key Companies Profiled
Market Forecast, Brand share analysis, Competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing
Key Questions Answered in the Report
Q1. Which is the Most Lucrative Market for Blister Packaging?
Currently, US is leading the global market for blister packaging. Sales in North America region will be over 30% of total demand throughout the forecast period.
Q2. Which is the Top-Selling Blister Packaging Product Type?
Carded is the most preferred blister packaging product in the market. The demand for carded blister is expected to increase further during the forecast period owing to ease of applicability and packaging structure
Q3. Which Material is Mostly used for Blister Packaging?
End users are mostly inclined towards use of plastic and aluminum based blister packaging solutions as these packaging formats offer more moisture resistance over others. Together, these segments are estimated to hold more than 70% market share attributing to its durability, stability and reusability.
Q4. Who are the Leading Players in the Blister Packaging Market?
Some of the leading companies offering blister packaging are Amcor plc, Constantia Flexibles GmbH, Sonoco Products Company, Winpak Ltd., Klockner Pentaplast Group, Honeywell International, Inc., Uflex Ltd, and ACG Pharmapack Pvt. Ltd .
Q5. Which End Use Segment Holds Major Portion Blister Packaging Market?
As per FMI Analysis, pharmaceutical segment is expected to capture major pie of market share in the global market. Following to this, veterinary & nutraceuticals market are expected to increase the sales of blister packaging in the near future.
Enquiry before Buying
Is this research conducted by Future Market Insights?
Yes, the research has been conducted by expert analysts of Future Market Insights through a combination of primary research and secondary research. To know more about how the research was conducted, you can speak to research analyst
What research methodology is followed by FMI?
FMI follows a methodology that encompasses demand side assessment of the market, and triangulates the same through supply side analysis. This methodology is based on use of standard market structure, methods and definitions. Request detailed methodology
Who are the respondents for primary research?
FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. For a full list of primary respondents, please reach out to us.
What are the sources of secondary research?
FMI conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Is a sample of this report available for evaluation?
Yes, you can request a sample and it will be sent to you through an email.
How can I buy this report?
FMI provides a secure online payment system to buy report seamlessly. You can buy the report securely and safely.
Blister Packaging Market by Category
- Cold Forming Technology
- Thermoforming technology
- Paper & Paperboard
- Veterinary and Nutraceuticals
- Medical Devices
- Electronics & Electricals
- Industrial Goods
- Consumer Goods
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific Ex. Japan (APEJ)
- Middle East and Africa (MEA)